市場調查報告書
商品編碼
1471960
心血管超音波心動圖市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍:按類型、技術、最終用戶和地理位置Cardiovascular Echocardiography Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Technology, End User, and Geography |
心血管超音波心臟檢查市場規模預計將從2022年的1,437.2億美元成長到2030年的2,000億美元;預計 2022 年至 2030 年複合年成長率為 4.2%。
心血管超音波心動圖是一種使用聲波創建心臟影像的測試。此測試程序通常針對疑似或已知患有心臟病的患者進行。此測試無痛,可揭示心臟狀況;此影像顯示了心臟的大小、形狀、心室和瓣膜及其功能。心血管超音波心動圖還可以辨識心臟收縮不正常的部分。使用超音波心動圖可以清楚地看到早期心臟病發作造成的損傷。用於檢測心臟疾病的常用診斷測試是經胸心臟超音波檢查,因為它是非侵入性的。心血管超音波心動圖市場的成長歸因於心血管疾病負擔的增加以及超音波心動圖設備相對於其他心臟診斷程序的優勢。然而,與超音波心動圖設備的使用相關的挑戰阻礙了心血管超音波心動圖市場的成長。
基於類型的見解
根據技術,心血管超音波心臟檢查市場分為2D超音波心臟檢查、3D超音波心動圖和多普勒。到 2022 年,3D 超音波心動圖細分市場將佔據重要的心血管超音波心動圖市場佔有率。 3D 超音波心動圖捕捉心臟結構的3D影像,用於提高影像品質和讀者信心並評估結構和功能。透過在心臟跳動時進行測量,即時影像可以更準確地評估心臟功能。心臟病患者的最佳治療方案可以透過 3D 回波來決定,它提供了心臟解剖結構的改進影像。在過去的二十年中,電腦和換能器技術的進步促進了 3D 超音波心動圖的發展,它為傳統 2D 超音波心動圖提供了重要的附加臨床資訊。與 2D 超音波心動圖相比,3D 超音波心動圖具有許多優點,例如更好地定量心臟體積、質量和功能,更好地顯示和評估瓣膜功能障礙;和更短的影像擷取時間。它還可以改善心臟結構之間複雜形狀和空間關係的可視化,這對心血管超音波心動圖市場的成長有正面影響。
基於指示的見解
根據最終用戶,心血管超音波心臟檢查市場分為醫院、門診手術中心和診斷實驗室。醫院細分市場在 2022 年佔據重要市場佔有率,預計 2022 年至 2030 年複合年成長率最高。
美國食品藥物管理局、世界衛生組織和疾病管制與預防中心是準備心血管超音波心動圖市場報告時參考的主要和次要來源之一。
註 - 將為以下提到的地區/國家提供類似的分析
The cardiovascular echocardiography market size is expected to grow from US$ 143.72 billion in 2022 to US$ 200.00 billion by 2030; it is projected to register a CAGR of 4.2% during 2022-2030.
Cardiovascular echocardiography is a test that uses sound waves to create images of the heart. This testing procedure is usually performed on patients with suspected or known heart diseases. The test is painless and reveals the condition of the heart; the image shows the size, shape, chambers, and valves of the heart and their functioning. The cardiovascular echocardiogram can also identify parts of the heart that are not contracting properly. The injuries from the earlier heart attack can be clearly visualized using echocardiographs. The commonly used diagnostic test for detecting cardiac disorders is transthoracic cardiac ultrasound owing to its non-invasive nature. The cardiovascular echocardiography market growth is attributed to the rising burden of cardiovascular diseases and the advantages of echocardiographic devices over other cardiac diagnostic procedures. However, challenges associated with the use of echocardiography devices hinder the growth of the cardiovascular echocardiography market.
Type-Based Insights
Based on technology, the cardiovascular echocardiography market is categorized into 2D echocardiogram, 3D echocardiogram, and Doppler. The 3D echocardiogram segment held a significant cardiovascular echocardiography market share in 2022. The segment is estimated to register the highest CAGR during the forecast period. The 3D echocardiogram captures three-dimensional images of the heart structures and is used to improve image quality and reader confidence and assess structure and functionality. With measurements made while the heart is beating, the real-time images offer a more accurate evaluation of cardiac function. The best course of treatment for a patient with heart disease can be decided with the 3-D echo, which provides improved images of the heart's anatomy. Over the past two decades, advancements in computer and transducer technologies have allowed the development of 3D echocardiography, which provides significant additional clinical information to traditional 2D echocardiography. Compared to 2D echocardiography, 3D echocardiography offers numerous benefits, such as better quantitation of cardiac volumes, mass, and function, better display and assessment of valve dysfunction; and shorter image acquisition times. It also allows for improved visualization of complex shapes and spatial relations between cardiac structures, which positively influences the growth of the cardiovascular echocardiography market.
Indication-Based Insights
Based on end user, the cardiovascular echocardiography market is segmented into hospitals, ambulatory surgery centers, and diagnostic labs. The hospitals segment held a significant market share in 2022 and is expected to register the highest CAGR during 2022-2030.
The US Food and Drug Administration, the World Health Organization, and the Centers for Disease Control and Prevention are among the primary and secondary sources referred to while preparing the cardiovascular echocardiography market report.
Note - Similar analysis would be provided for below mentioned regions/countries
Note - Similar information would be provided for below list of companies